Reckitt third-quarter sales top estimates on coronavirus demand for cleaning products


© Reuters. FILE PHOTO: Products produced by Reckitt Benckiser; Vanish, Finish, Dettol and Harpic are seen in London

By Martinne Geller

LONDON (Reuters) – Reckitt Benckiser (L:) reported on Tuesday a much bigger-than-expected rise in third-quarter sales and raised its full-year outlook, as the coronavirus pandemic lifts demand for its cleaning products.

The British maker of Dettol and Lysol said its plan to rejuvenate sales following years of difficulties may be achieved a year earlier than expected.

“While there is still more work to do, I’m pleased to say that RB today is in much better shape than it was a year ago,” Chief Executive Laxman Narasimhan, who has been in the role for a year, told reporters.

Reckitt shares were up 2% at 0705 GMT in London. They had gained 17.5% this year by Monday’s close.

The company said sales on a like-for-like basis, excluding items such as foreign exchange fluctuations, rose 13.3%. Analysts on average expected a 9.5% increase, according to a consensus provided by the company.

Quarterly net revenue was 3.51 billion pounds, up from 3.21 billion pounds a year earlier.

The company raised its full-year net revenue outlook, saying it expects a low double-digit rise, up from a previous forecast of high single-digit growth.

Like-for-like sales rose 19.5% in the company’s hygiene business in the third quarter, 12.6% in its health business, which includes Durex condoms and Mucinex cold medicine, and 4.1% in its nutrition business, which includes Enfamil baby formula.

The COVID-19 pandemic has relieved pressure on a business that has struggled against intense competition in the health and hygiene sectors for several years.

READ  Dow Cuts Some Losses as Pelosi Rejects Piecemeal Stimulus

Reckitt is preparing to sell some of its personal care brands, including Veet hair removal cream and Clearasil acne cream, Reuters reported last month.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





READ SOURCE

LEAVE A REPLY

Please enter your comment!
Please enter your name here